Mucosis' Grant

Mucosis raised a round of funding on May 31, 2010. Investors include Agentschap.

Mucosis is a clinical-stage Dutch biotechnology company with a proprietary platform technology, Mimopath, on which it develops novel vaccines using various routes of administration including those tha…

Articles about Mucosis' Grant: